Latest filing published 30 Jun 2025 for Vivoryon Therapeutics N.V.. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
S.N. Shah is a declared insider of Vivoryon Therapeutics N.V., with filings sourced from AFM. Between 22 June 2022 and 30 June 2025, the trades on record add up to 3 filings.
Purchases make up the whole of the open-market record (3 purchases). No amount is published for 3 filings, which the totals therefore leave out. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Since January 2025: 1 purchase and no sales on the market.
The latest filing, published on 30 June 2025, reports an open-market purchase in Vivoryon Therapeutics N.V. These figures are compiled from regulatory filings published by AFM. They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.